Quick Takeaways
- This page summarizes Jonathan D. Root's Form 4 filing for Edgewise Therapeutics, Inc. (EWTX).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 12 Jun 2024, 19:22.
Jonathan D. Root - 10 Jun 2024 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)
- Role
- Director
- Signature
- /s/ John R. Moore Attorney-in-Fact for Jonathan Root M.D.
- Issuer symbol
- EWTX
- Transactions as of
- 10 Jun 2024
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 12 Jun 2024, 19:22:48 UTC
- Previous filing
- 26 Apr 2024
- Next filing
- 19 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Jonathan D. Root filed Form 4 for Edgewise Therapeutics, Inc. (EWTX) on 12 Jun 2024."
What Changed
- Previous filing in this sequence was filed on 26 Apr 2024.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
EWTX
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +20,594
- Change %
- Price
- $0.000000
- Shares after
- 20,594
- Date
- 10 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,594
- Exercise price
- $17.13
- Footnotes
- F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | 100% of the Stock Options granted on June 10, 2024 will become vested on the earlier of (i) June 10, 2025 or (ii) the business day prior to the date of the 2025 annual meeting of stockholders. |